Live Breaking News & Updates on Novabay Pharmaceuticals Trading Down

Stay updated with breaking news from Novabay pharmaceuticals trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NovaBay Pharmaceuticals (NYSE:NBY) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a report issued on Friday. The firm issued a sell rating on the stock. NovaBay Pharmaceuticals Trading Down 1.2 % Shares of NBY stock opened at $0.12 on Friday. The stock has a market capitalization of $4.49 million, a P/E ratio of […] ....

United States , Novabay Pharmaceuticals Inc , Hedge Funds Weigh In On Novabay Pharmaceuticals , Novabay Pharmaceuticals , Novabay Pharmaceuticals Trading Down , News Ratings For Novabay Pharmaceuticals Daily , Armistice Capital , Novabay Pharmaceuticals Company Profile , Free Report , Bay Pharmaceuticals Trading Down , Bay Pharmaceuticals , Get Free Report , Avenova Spray , Novabay Pharmaceuticals Daily ,

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Share Price Crosses Below 50-Day Moving Average of $0.74

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.74 and traded as low as $0.19. NovaBay Pharmaceuticals shares last traded at $0.19, with a volume of 19,517,809 shares trading hands. NovaBay Pharmaceuticals […] ....

United States , Novabay Pharmaceuticals , News Ratings For Novabay Pharmaceuticals Daily , Novabay Pharmaceuticals Company Profile , Armistice Capital , Virtu Financial , Novabay Pharmaceuticals Inc , Renaissance Technologies , Novabay Pharmaceuticals Trading Down , Get Free Report , Bay Pharmaceuticals , Bay Pharmaceuticals Trading Down , Avenova Spray , Novabay Pharmaceuticals Daily , Nyseamerican Nby ,

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Trading Down 17.0 % NYSEAMERICAN NBY opened at $0.73 on Friday. The company’s fifty day simple moving average is $0.92 […] ....

United States , Institutional Trading Of Novabay Pharmaceuticals , Novabay Pharmaceuticals , Virtu Financial , Renaissance Technologies , Armistice Capital , News Ratings For Novabay Pharmaceuticals Daily , Novabay Pharmaceuticals Company Profile , Novabay Pharmaceuticals Inc , Novabay Pharmaceuticals Trading Down , Get Rating , Bay Pharmaceuticals Trading Down , Bay Pharmaceuticals , Avenova Spray , Novabay Pharmaceuticals Daily , Nyseamerican Nby , Initiated Coverage , Stocknews Com ,

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research note released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Trading Down 1.4 % Shares of NBY opened at $0.71 on Friday. NovaBay Pharmaceuticals has a 1-year low of $0.48 and a 1-year […] ....

United States , Novabay Pharmaceuticals , News Ratings For Novabay Pharmaceuticals Daily , Novabay Pharmaceuticals Inc , Novabay Pharmaceuticals Trading Down , Novabay Pharmaceuticals Company Profile , Virtu Financial , Renaissance Technologies , Armistice Capital , Institutional Trading Of Novabay Pharmaceuticals , Get Rating , Bay Pharmaceuticals Trading Down , Bay Pharmaceuticals , Capital Management , Avenova Spray , Novabay Pharmaceuticals Daily ,

StockNews.com Initiates Coverage on NovaBay Pharmaceuticals (NYSEAMERICAN:NBY)

Equities research analysts at StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research report issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Trading Down 1.4 % NBY stock opened at $0.68 on Thursday. The stock has a 50-day moving average price […] ....

Novabay Pharmaceuticals Trading Down , News Ratings For Novabay Pharmaceuticals Daily , Renaissance Technologies , Virtu Financial , Novabay Pharmaceuticals , Armistice Capital , Hedge Funds Weigh In On Novabay Pharmaceuticals , Novabay Pharmaceuticals Inc , Get Rating , Bay Pharmaceuticals Trading Down , Bay Pharmaceuticals , Capital Management , Novabay Pharmaceuticals Daily ,